Jianfei Qian, PhD

Jianfei Qian received both his DVM and PhD in China. In 2002, he came to the US as a postdoctoral research fellow in Dr. Qing Yi’s lab at the University of Arkansas for Medical Sciences. In 2018, he was recruited as an assistant research professor at The Houston Methodist Research Institute. His research is focused on the development of novel immunotherapy methods to treat multiple myeloma (MM) and other cancers by using anti-tumor-specific monoclonal antibodies (mAbs), identifying new cancer-specific antigens, and developing novel tumor vaccines.

Qiang Wang, PhD

Qiang Wang received his PhD in Microbiology at University of Chinese Academy of Science where he focused on molecular mechanisms of Influenza A virus replication. During his postdoctoral training at Lerner Research Institute of Cleveland Clinic, Wang developed a series of experimental methods to investigate the cross-talk between the tumor microenvironment and multiple myeloma. He has broad interests in the regulation of myeloma intrinsic and extrinsic drug resistance. In his free time, he enjoys outdoor activities with his family, watching movies, and playing basketballs.

Liuling Xiao, PhD

Luiling graduated from Fudan University, Shanghai, China in 2017, and started the postdoctoral fellow training from September, 2017. My present project focuses on exploring the role of CD8+ T cells in the melanoma and multiple myeloma

Chuanchao Zhang, PhD

Chuanchao Zhang received his PhD degree in Beijing institute of Genomics, Chinese Academy of Science. He previously worked on DNA damage response, long non-coding RNAs and small peptides. He is well trained in molecular and cell biology and proficient in systematic analysis pipeline for high-throughput sequencing data, including RNA-seq, Chip-seq, PAR-CLIP-seq, etc. His current project focus is on the regulation of multiple myeloma and intrigued by tumor immunity, such as CAR-T. Looking forward to participating in related work in the future.

Yufei Zhang, PhD

Yufei Zhang received his bachelor of medicine and PhD from Fudan University and became a postdoctoral fellow at Houston Methodist Hospital in 2024. He is a well-trained scientist in biomedical sciences with a broad background in medicine and immunology. His research interest cover translational and clinical study in cancer immunotherapy including CAR-T cell therapy and cancer vaccine.

Wei Wu, PhD

Wei Wu received his PhD in Biochemistry and Molecular Biology at University of Chinese Academy of Science in 2022, and started the postdoctoral fellow training from Jan, 2024. His present project focuses on investigating the cross-talk between the tumor microenvironment and multiple myeloma.

Rui Duan, PhD

Rui Duan received her PhD in Basic Medicine at Southern Medical University in Jun 2023, and started the postdoctoral fellow training at Houston Methodist Hospital from Dec 2023. Her present project focuses on exploring the CD8+ T cells-induced pyroptosis in the melanoma.

Ling Zhong, PhD

Ling Zhong graduated from Sichuan University, Chengdu, China, and started the postdoctoral fellow training from Feburary, 2022. She focus on the pathogenesis of multiple myeloma, especially high-risk myeloma.

Qi Guo, PhD

Qi Guo earned his MD and PhD from Lanzhou University in 2022 and became a postdoctoral fellow at Houston Methodist Hospital in 2023. He is a well-trained scientist specializing in metabolic diseases, with a broad background in medicine and immunology. His research focuses on uncovering the relationship between cancer cell metabolism and the immune response.